Blogs

When combined with healthcare's rising costs, competition, and complexity, the shift towards value-oriented, consumer-driven healthcare is encouraging employers to rethink benefit plans. To remain competitive, employers are adopting innovative plans that simplify and enhance the employee experience while reducing costs for them.

One of the biggest challenges in managing population health is converting and delivering actionable information to appropriate resources. Defining patient populations is an essential first step in identifying opportunities for clinical improvement. However, this can be a challenging task. Registry Builder makes it easy for clinicians to find a specific patient population and turn the analytics into actionable steps that improve outcomes.

Patient engagement is a key contributor to improved health outcomes and better patient-provider connections. As patients become more tech-savvy and curious about their health, keeping patients engaged becomes increasingly important. Patients also seek guidance and support from medical professionals during the course of their medical treatment, making easy-to-use channels of engagement more essential. To inform and engage patients, healthcare institutions are using technologies like mobile applications, patient portals and smart devices, to name a few. However, delivering a quality experience for patients starts by establishing an effective strategy for smarter patient engagement.

“Patient-centeredness” is a facet of healthcare that suggests taking the power out of the hands of those who give care and into the hands of those who receive it. Yet, it is not only about surrendering to patients’ requests. Rather it is about teamwork and trust among the clinicians, patients, and patients’ families.

Physicians often rely on referrals for new patient flow through their practice. Unfortunately, most doctors network incorrectly, inconsistently and ineffectively.

The life science industry today has a significant opportunity at hand with the surge in data dependency. With the legislation of the 21st Century Cures Act, data has become the fuel for accelerating the drug development and innovation processes. The Cures Act defines the real-world evidence (RWE) as the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of the real-world data (RWD). This facilitates an accurate view of the patient populations comprising larger socioeconomic, racial, age, and gender diversity, mostly un-represented by the RCTs.